Total Payments
$1.4M
2023 Payments
$21.35
Companies
14
Transactions
116
Payment Breakdown by Category
Consulting$1.2M (86.0%)
Other$169,134 (11.9%)
Travel$22,047 (1.6%)
Research$2,800 (0.2%)
Education$2,686 (0.2%)
Food & Beverage$1,772 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.2M | 38 | 86.0% |
| Grant | $157,200 | 2 | 11.1% |
| Travel and Lodging | $22,047 | 29 | 1.6% |
| Honoraria | $11,934 | 1 | 0.8% |
| Unspecified | $2,800 | 1 | 0.2% |
| Education | $2,686 | 7 | 0.2% |
| Food and Beverage | $1,772 | 38 | 0.1% |
Payments by Type
General
$1.4M
115 transactions
Research
$2,800
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $1.3M | 38 | $0 (2022) |
| Horizon Pharma plc | $86,383 | 7 | $0 (2018) |
| Janssen Research & Development, LLC | $19,039 | 20 | $0 (2018) |
| sanofi-aventis U.S. LLC | $10,750 | 7 | $0 (2017) |
| EMD Serono Research & Development Institute | $6,286 | 8 | $0 (2017) |
| SANOFI US SERVICES INC. | $4,452 | 5 | $0 (2018) |
| Celgene Corporation | $3,402 | 5 | $0 (2018) |
| AstraZeneca UK Limited | $3,367 | 7 | $0 (2020) |
| Eli Lilly and Company | $2,945 | 3 | $0 (2020) |
| Mylan Pharmaceuticals Inc. | $2,686 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $21.35 | 1 | Lilly USA, LLC ($21.35) |
| 2022 | $79,200 | 1 | Horizon Therapeutics plc ($79,200) |
| 2021 | $87,744 | 2 | Horizon Therapeutics plc ($87,744) |
| 2020 | $326,908 | 24 | Horizon Therapeutics plc ($321,157) |
| 2019 | $789,930 | 19 | Horizon Therapeutics plc ($788,368) |
| 2018 | $19,783 | 21 | Janssen Research & Development, LLC ($12,039) |
| 2017 | $113,873 | 48 | Horizon Pharma plc ($85,815) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $21.35 | General |
| 12/02/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $79,200.00 | General |
| Category: KRYSTEXXA | ||||||
| 12/02/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Grant | Cash or cash equivalent | $79,200.00 | General |
| Category: KRYSTEXXA | ||||||
| 11/10/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $8,544.00 | General |
| Category: KRYSTEXXA | ||||||
| 12/15/2020 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $2,790.00 | General |
| 11/19/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Grant | Cash or cash equivalent | $78,000.00 | General |
| Category: KRYSTEXXA | ||||||
| 11/03/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 09/21/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $48,048.00 | General |
| Category: KRYSTEXXA | ||||||
| 09/21/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $31,158.00 | General |
| Category: KRYSTEXXA | ||||||
| 02/29/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $78.66 | General |
| Category: KRYSTEXXA | ||||||
| 02/29/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $54.25 | General |
| Category: KRYSTEXXA | ||||||
| 02/29/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $38.16 | General |
| Category: KRYSTEXXA | ||||||
| 02/28/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $11,934.00 | General |
| Category: KRYSTEXXA | ||||||
| 02/28/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $1,694.68 | General |
| Category: KRYSTEXXA | ||||||
| 02/28/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $142.86 | General |
| Category: KRYSTEXXA | ||||||
| 02/28/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $84.99 | General |
| Category: KRYSTEXXA | ||||||
| 02/28/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $38.16 | General |
| Category: KRYSTEXXA | ||||||
| 02/27/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $490.37 | General |
| Category: KRYSTEXXA | ||||||
| 02/27/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $417.04 | General |
| Category: KRYSTEXXA | ||||||
| 02/27/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $250.00 | General |
| Category: KRYSTEXXA | ||||||
| 02/23/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $63,445.06 | General |
| Category: KRYSTEXXA | ||||||
| 02/18/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| Category: KRYSTEXXA | ||||||
| 02/12/2020 | Eli Lilly and Company | — | — | Cash or cash equivalent | $2,800.00 | Research |
| 02/07/2020 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 02/06/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $45,500.00 | General |
| Category: KRYSTEXXA | ||||||
About Dr. Peter Lipsky, M.D
Dr. Peter Lipsky, M.D is a Rheumatology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2014. The National Provider Identifier (NPI) number assigned to this provider is 1225441363.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Lipsky, M.D has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $21.35 received in 2023. These payments were reported across 116 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($1.2M).
Ad
Practice Information
- Specialty Rheumatology
- Location Charlottesville, VA
- Active Since 06/06/2014
- Last Updated 06/06/2014
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225441363
Products in Payments
- KRYSTEXXA (Biological) $1.3M
- KRYSTEXXA (Drug) $85,833
- NO PRODUCT DISCUSSED (Drug) $15,203
- STELARA (Biological) $8,817
- SIMPONI (Biological) $8,000
- Glatiramer Acetate (Drug) $2,686
- Atacicept (Biological) $1,000
- RAYOS (Drug) $420.28
- TEPRO (Drug) $130.00
- CC-220 (Drug) $23.33
- FLECTOR (Drug) $16.29
- TALTZ (Drug) $13.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Charlottesville
Jae Hee Yun, M.d, M.D
Rheumatology — Payments: $40,375
Rheumatology $40,375
Donald Kimpel
Rheumatology — Payments: $17,872
Rheumatology $17,872
Dr. Brian King, M.d, M.D
Rheumatology — Payments: $520.36
Rheumatology $520.36
Paul Katzenstein, M.d, M.D
Rheumatology — Payments: $349.47
Rheumatology $349.47
Janet Lewis
Rheumatology — Payments: $203.91
Rheumatology $203.91
Gitanjali Khurana, M.d, M.D
Rheumatology — Payments: $16.25
Rheumatology $16.25